Noscendo GmbH
PrivateLast Round
Series B
May 16, 2022
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Noscendo GmbH is a biotechnology company that develops bioinformatic solutions and diagnostic platforms to identify and assess pathogens in bloodstream-associated and related infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noscendo GmbH Comparables
Compare Noscendo GmbH with similar companies based on industry and business-model similarity.
Noscendo GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 16, 2022 | ||||
| Series A | Apr 23, 2020 | ||||
| Seed | Oct 31, 2018 |
Noscendo GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Revent Capital | Series B |
| Wieland Capital | Series B, Series A, Seed |
| High-Tech Gründerfonds | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 43, 2.7x the trailing average.
- Jul 20, 2026
Open roles increased to 43, representing 102% of headcount.
Recent news
Latest coverage and updates
- sells_assets_toJul 16, 2026
Noscendo sold assets to Bruker Corporation on Jul 15th '26.
Noscendo GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access